M.D.C. (NYSE:MDC) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of M.D.C. (NYSE:MDCFree Report) in a report issued on Wednesday. The brokerage issued a hold rating on the construction company’s stock.

A number of other research firms also recently commented on MDC. Evercore ISI downgraded M.D.C. from an outperform rating to an in-line rating and increased their target price for the company from $57.00 to $63.00 in a research report on Wednesday, January 31st. Raymond James restated a market perform rating on shares of M.D.C. in a research report on Wednesday, February 7th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the stock. According to MarketBeat, the company currently has an average rating of Hold and an average target price of $52.13.

View Our Latest Analysis on MDC

M.D.C. Trading Down 0.1 %

M.D.C. stock opened at $62.92 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 9.76 and a quick ratio of 3.92. The firm’s 50 day moving average price is $62.63 and its 200-day moving average price is $52.13. M.D.C. has a 1 year low of $36.47 and a 1 year high of $63.00. The stock has a market cap of $4.72 billion, a P/E ratio of 11.92 and a beta of 1.54.

M.D.C. (NYSE:MDCGet Free Report) last released its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the prior year, the firm earned $1.08 EPS. The business’s revenue was down 11.9% on a year-over-year basis. On average, equities analysts predict that M.D.C. will post 5.38 earnings per share for the current fiscal year.

M.D.C. Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 21st. Investors of record on Wednesday, February 7th were paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 3.50%. The ex-dividend date was Tuesday, February 6th. M.D.C.’s dividend payout ratio (DPR) is 41.67%.

Insider Activity

In other news, Director David E. Blackford sold 6,200 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $62.69, for a total value of $388,678.00. Following the sale, the director now directly owns 13,534 shares in the company, valued at approximately $848,446.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 23.30% of the company’s stock.

Institutional Trading of M.D.C.

Several large investors have recently bought and sold shares of the stock. WealthPLAN Partners LLC acquired a new position in shares of M.D.C. in the 4th quarter valued at $992,000. Raymond James & Associates raised its stake in shares of M.D.C. by 23.0% in the fourth quarter. Raymond James & Associates now owns 898,855 shares of the construction company’s stock worth $49,662,000 after purchasing an additional 168,214 shares during the last quarter. Tudor Investment Corp Et Al lifted its holdings in shares of M.D.C. by 0.8% during the third quarter. Tudor Investment Corp Et Al now owns 117,754 shares of the construction company’s stock worth $4,855,000 after purchasing an additional 977 shares during the period. Alps Advisors Inc. purchased a new stake in M.D.C. in the third quarter valued at approximately $1,803,000. Finally, Swiss National Bank increased its holdings in M.D.C. by 22.7% in the 3rd quarter. Swiss National Bank now owns 136,643 shares of the construction company’s stock worth $5,634,000 after buying an additional 25,300 shares during the period. Hedge funds and other institutional investors own 88.08% of the company’s stock.

About M.D.C.

(Get Free Report)

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Stories

Analyst Recommendations for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.